Overview

Our lab has two areas of focus. The first is the study of mechanisms of non-alcoholic fatty liver disease – the most common cause of liver disease in North America. Our particular area of expertise is in combining genomic and proteomic analyses to generate insights into the pre- and posttranscriptional events that produce the hepatic phenotype associated with this condition. Current work includes study of the protein basis of the histological spectrum of non-alcoholic fatty liver disease, from simple steatosis to steatohepatitis with fibrosis.

Read More
Photo of Michael R         Charlton M.D.
"The combination of scientific and clinical resources at Mayo provide a unique opportunity for discovery. We take full advantage of these resources in generating new insights into the twin epidemics of fatty liver disease and viral hepatitis."

Appointments | Contact Us | Give to Mayo Clinic | Search